-
48913
TCL PESTICIDES MIX 1X1ML & 2000UG/ML TOLUENE:HEXANE(50:50) (C15-1304-000)
Price: $298.29List Price: $331.43Application Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support. -
790435-25MG
TCO PEG4 succinimidyl ester (C15-1308-973)
Price: $1,128.60List Price: $1,254.00Application Succinimidyl ester/NHS (amine reactive) functionalized trans-cyclooctene derivative for incorporation of the cyclooctene moiety into amine containing compounds or biomolecules. Trans-cyclooctenes are useful in strain-promoted, -
790435-5MG
TCO PEG4 succinimidyl ester (C15-1308-974)
Price: $499.04List Price: $554.49Application Succinimidyl ester/NHS (amine reactive) functionalized trans-cyclooctene derivative for incorporation of the cyclooctene moiety into amine containing compounds or biomolecules. Trans-cyclooctenes are useful in strain-promoted, -
8510938025
TDBA 25 MG
Price: $602.57List Price: $669.52A highly sensitive photocross-linker.activated at 300 nm for the preparation of photoactivatable biological probes [1] . -
-
Ab175669-100μgTeclistamab (anti-CD3 &: BCMA) is a human bispecific antibody to BCMA and CD3 that recognizes BCMA on target cells and CD3 on T cells and induces T cell-mediated cytotoxicity leading to T cell activation and subsequent target cell lysis.
-
Ab175669-10mgTeclistamab (anti-CD3 &: BCMA) is a human bispecific antibody to BCMA and CD3 that recognizes BCMA on target cells and CD3 on T cells and induces T cell-mediated cytotoxicity leading to T cell activation and subsequent target cell lysis.
-
-
T671248-1mgTeduglutide (rdna origin).
-
45756-250MG-R
Teflubenzuron (C15-1284-193)
Price: $170.65List Price: $189.61Legal Information PESTANAL is a registered trademark of Sigma-Aldrich International GmbH -
CRM01399-100MG
TEFLUBENZURON (C15-1284-194)
Price: $278.57List Price: $309.52This certified reference material (CRM) is produced and certified in accordance with ISO/IEC 17025 and ISO 17034. This CRM is traceable to primary material from an NMI, e. -
Ab182746-100μgTelisotuzumab (anti-HGFR) is a human recombinant bivalent antibody, a therapeutic antibody against the hepatocyte growth factor receptor (MET) that binds c-Met with high affinity and inhibits c-Met signaling. Telisotuzumab (anti-HGFR) has antitumor